Epithelial cancers are primarily affected by KRAS mutations, with approximately 90% of pancreatic adenocarcinomas (PAAD) associated with KRAS mutations, followed by colorectal carcinoma (45%) and lung adenocarcinoma (30%) [1]. The gene discussed is KRAS; the disease is pancreatic adenocarcinoma.